Showing results (71-80 of 201) with videos related to
Sort By:
Pageof 21
Leukemia Research|August 4, 2004
Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemiaAndrew S Daly, Suzanne Kamel-Reid, Jeffrey H Lipton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemiaDong Hwan Dennis Kim, Lakshmi Sriharsha, Wei Xu, et al.Oncology Nursing Forum|July 5, 2022
A Qualitative Study of the Everyday Impacts of Cognitive Difficulties After Stem Cell TransplantationSamantha J Mayo, Isabel Wozniczka, Beth Edwards, et al.Journal of Psychosomatic Research|October 29, 2003
Self-concept as a "BMT patient", illness intrusiveness, and engulfment in allogeneic bone marrow transplant recipientsHeather J Beanlands, Jeffrey H Lipton, Elizabeth A McCay, et al.Hematology (Amsterdam, Netherlands)|March 8, 2003
Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donorsWanda Hasegawa, Jeffrey H Lipton, Hans A Messner, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2011
A prospective study comparing the outcomes and health-related quality of life in adult patients with myeloid malignancies undergoing allogeneic transplantation using myeloablative or reduced-intensity conditioningVikas Gupta, Tony Panzarella, Le Li, et al.Leukemia Research|November 16, 2004
Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL)Vikas Gupta, Qi-long Yi, Joseph Brandwein, et al.Annals of Hematology|January 8, 2021
Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin levelWarren Fingrut, Arjun Law, Wilson Lam, et al.Bone Marrow Transplantation|October 16, 2019
My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adultsRehab M Alblooshi, Uday Deotare, Fotios V Michelis, et al.Annals of Hematology|June 28, 2018
Fludarabine and busulfan plus low-dose TBI as reduced intensity conditioning in older patients undergoing allogeneic hematopoietic cell transplant for myeloid malignanciesManar M I Khalil, Hans A Messner, Jeffrey H Lipton, et al.Pageof 21